A global survey on the use of the international classification of diseases codes for metabolic dysfunction-associated fatty liver disease
2024 · Hepatology International · 29 citations
https://doi.org/10.1007/s12072-024-10702-5
J
Joost Boeckmans
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
62
Papers
768
Citations
16
h-index
22
i10-index
Joost Boeckmans is an academic researcher. The author has contributed to research in topics: Liver Disease Diagnosis and Treatment & Liver physiology and pathology & Endoplasmic Reticulum Stress and Disease. The author has an h-index of 16, co-authored 53 publications.
ORCID: 0000-0001-8399-5872Papers by this author
worksClinical utility of the Fibrosis-4 index for predicting mortality in patients with heart failure with or without metabolic dysfunction-associated steatotic liver disease: a prospective cohort study
2024 · The Lancet Regional Health - Europe · 19 citations
https://doi.org/10.1016/j.lanepe.2024.101153
Inflammation in liver fibrosis and atrial fibrillation: A prospective population-based proteomic study
2024 · JHEP Reports · 12 citations
https://doi.org/10.1016/j.jhepr.2024.101171
Transcriptomics data of a human in vitro model of non-alcoholic steatohepatitis exposed to elafibranor
2019 · Data in Brief · 4 citations
https://doi.org/10.1016/j.dib.2019.104093
Clinical Utility of Non‐Invasive Tests for Liver Fibrosis in People Living With Alpha‐1 Antitrypsin Deficiency
2025 · Liver International · 0 citations
https://doi.org/10.1111/liv.70165
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat